Tellgen Corporation (300642.SZ): Two products obtained medical device registration certificates.

date
19:53 18/09/2026
avatar
GMT Eight
Tellgen Corporation (300642.SZ) announced that its controlling subsidiaries, Jiangxi Tellgen Life Technology Co., Ltd. ("Jiangxi Tellgen") and Shanghai Maishi Biotechnology Co., Ltd. ("Maishi Biotech"), recently obtained medical device registration certificates issued by the Jiangxi Provincial Medical Products Administration and the Shanghai Municipal Medical Products Administration, respectively. The products involved are: "Fully Automated Flow Fluorescence Immunoassay Analyzer (Model/Specification: TESMIF5000, TESMIF5000M)" and "Four-Item Antiepileptic Drug Concentration Assay Kit (Liquid Chromatography-Tandem Mass Spectrometry Method)".
Tellgen Corporation (300642.SZ) announced that its controlling subsidiaries Jiangxi Tellgen Corporation Technology Co., Ltd. (hereinafter referred to as "Jiangxi Tellgen") and Shanghai Maishi Biotechnology Co., Ltd. (hereinafter referred to as "Maishi Biotechnology") recently obtained medical device registration certificates issued by the Jiangxi Provincial Medical Products Administration and the Shanghai Municipal Medical Products Administration, respectively. The products involved are: "Fully Automated Flow Cytometric Fluorescence Immunoassay Analyzer (Model/Specification: TESMIF5000, TESMIF5000M)" and "Four-Item Antiepileptic Drug Concentration Assay Kit (Liquid Chromatography-Tandem Mass Spectrometry Method)".